Trending at Lumira Ventures

FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System

Alyssia Watkin Portfolio News, Main Page, HistoSonics

HistoSonics®, (, the manufacturer of the Edison® System and novel histotripsy therapy platforms, announced today the marketing authorization of its “Breakthrough” platform via the U.S. Food and Drug Administration’s (FDA) De Novo Classification Request process, a rigorous pre-market review pathway for …

HistoSonics Announces $40 Million Financing

admin Portfolio News, HistoSonics

Breakthrough medical platform offers vision of non-invasive procedures to eliminate diseased tissues and tumors MINNEAPOLIS, June 8, 2020 /PRNewswire/ — HistoSonics, developer of a non-invasive robotic platform and sonic beam therapy, announced today that it has closed $40 million in an …